©The Author(s) 2019.
World J Gastroenterol. Aug 14, 2019; 25(30): 4246-4260
Published online Aug 14, 2019. doi: 10.3748/wjg.v25.i30.4246
Published online Aug 14, 2019. doi: 10.3748/wjg.v25.i30.4246
Table 4 Number of responders matching each predetermined patient profile
| Profiles | n | |
| Compound | ||
| 1 | Patients with active disease (MIBDI A/B/C) and a history of hospitalization during the preceding 12 mo | 94 |
| 2 | Patients with significantly active disease (MIBDI A/B/C) treated with immunomodulators and biologic agents | 52 |
| 3 | Patients in remission while treated with immunomodulators and/or biologic agents | 26 |
| 4 | Patients in remission treated only with mesalamine or receiving no treatment | 90 |
| 5 | Patients aged 21-65 yr with any active disease (MIBDI A/B/C/D) | 341 |
| 6 | Patients with any active disease (MIBDI A/B/C/D) and a previous surgery for IBD | 92 |
| 7 | Patients older than age 50 yr, diagnosed during the preceding 12 mo | 8 |
| 8 | Patient younger than age 21 yr, diagnosed during the preceding 12 mo | 21 |
| Simple | ||
| 9 | Patients diagnosed during the preceding 12 mo | 92 |
| 10 | Patients hospitalized during the preceding 12 mo | 163 |
| 11 | Patients diagnosed more than 10 yr ago | 212 |
| 12 | Patients who had surgery during the preceding 12 mo | 39 |
| 13 | Patients with highly disease activity (MIBDI A/B) | 246 |
| 14 | Patients diagnosed at age > 50 yr | 72 |
| 15 | Patients who were unemployed or received disability pension during the preceding 12 mo | 45 |
- Citation: Daher S, Khoury T, Benson A, Walker JR, Hammerman O, Kedem R, Naftali T, Eliakim R, Ben-Bassat O, Bernstein CN, Israeli E. Inflammatory bowel disease patient profiles are related to specific information needs: A nationwide survey. World J Gastroenterol 2019; 25(30): 4246-4260
- URL: https://www.wjgnet.com/1007-9327/full/v25/i30/4246.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i30.4246